Huang Xiaoyin, Chen Qianni, Su Qingling, Gong Jiamin, Wu Liqin, Xiang Liangguang, Li Wanxin, Chen Jun, Zhao Hongwei, Huang Wuqing, Du Shanshan, Ye Weimin
Department of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.
Department of Ultrasonography, Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, People's Republic of China.
Clin Epidemiol. 2025 Mar 24;17:287-302. doi: 10.2147/CLEP.S508514. eCollection 2025.
We aimed to identify the association between obesity and nonalcoholic fatty liver disease (NAFLD) and to quantify the mediating effects of insulin resistance (IR) and chronic inflammation through observational studies and Mendelian randomization (MR).
In the current study, three IR-related indicators and three indicators of inflammation were included. The individual and combined mediated effects of IR and inflammation in the association between obesity and NAFLD were investigated in two cross-sectional studies, the Fuqing Cohort from China and the National Health and Nutrition Examination Survey (NHANES). Total, direct, and indirect effects were estimated through direct counterfactual imputation estimation, and the proportion of mediating effects was calculated. We applied a two-step MR to determine the causal mediating role of IR and chronic inflammation in the pathway between obesity and NAFLD by using single nucleotide polymorphisms as instrumental variables to predict obesity, IR, and inflammation genetically.
In the Fuqing Cohort, all obese phenotypes were associated with an elevated NAFLD risk. Moreover, indicators of IR such as homeostatic model assessment of insulin resistance (HOMA-IR) and indicators of inflammation such as C-reactive protein (CRP) were significantly and positively associated with NAFLD risk. Individuals with obesity had significantly higher levels of IR and inflammation indicators compared to non-obese individuals. The indirect proportions of insulin and HOMA-IR accounted for 50.97-66.72% in the associations between obese phenotypes and NAFLD risk, while the proportions of inflammation indicators were < 14%. Similar results were observed in the NHANES analysis. In the MR analysis, the indirect effects of HOMA-IR and CRP were statistically significant with a greater mediated proportion explained by HOMA-IR than CRP.
Through two population-based studies and MR, we found the causal mediation roles of IR and inflammation in the association between obesity and NAFLD, in which HOMA-IR and CRP showed stable, significant mediation effects. Furthermore, HOMA-IR showed a higher mediation effect than CRP. We emphasize the vital role of HOMA-IR in NAFLD monitoring.
我们旨在通过观察性研究和孟德尔随机化(MR)确定肥胖与非酒精性脂肪性肝病(NAFLD)之间的关联,并量化胰岛素抵抗(IR)和慢性炎症的中介作用。
在本研究中,纳入了三个与IR相关的指标和三个炎症指标。在两项横断面研究中,即来自中国的福清队列研究和美国国家健康与营养检查调查(NHANES),研究了IR和炎症在肥胖与NAFLD关联中的个体及联合中介作用。通过直接反事实归因估计来估计总效应、直接效应和间接效应,并计算中介作用的比例。我们应用两步MR法,以单核苷酸多态性作为预测肥胖、IR和炎症的遗传工具变量,来确定IR和慢性炎症在肥胖与NAFLD之间通路中的因果中介作用。
在福清队列中,所有肥胖表型均与NAFLD风险升高相关。此外,胰岛素抵抗稳态模型评估(HOMA-IR)等IR指标以及C反应蛋白(CRP)等炎症指标与NAFLD风险显著正相关。与非肥胖个体相比,肥胖个体的IR和炎症指标水平显著更高。在肥胖表型与NAFLD风险的关联中,胰岛素和HOMA-IR的间接比例占50.97%-66.72%,而炎症指标的比例<14%。在NHANES分析中也观察到了类似结果。在MR分析中,HOMA-IR和CRP的间接效应具有统计学意义,且HOMA-IR解释的中介比例大于CRP。
通过两项基于人群的研究和MR,我们发现了IR和炎症在肥胖与NAFLD关联中的因果中介作用,其中HOMA-IR和CRP显示出稳定、显著的中介效应。此外,HOMA-IR的中介效应高于CRP。我们强调HOMA-IR在NAFLD监测中的重要作用。